David Mann
Impact in
- Neurology top 10%
- Parkinson's Disease Mechanisms and Treatments
- Amyotrophic Lateral Sclerosis Research
- Neurological diseases and metabolism
- Neuroinflammation and Neurodegeneration Mechanisms
-
- Alzheimer's disease research and treatments
Papers in
-
- Alzheimer's disease research and treatments 4
-
- Prion Diseases and Protein Misfolding 2
- Co-authors
- Masato Hasegawa (2 shared papers)Takeshi Iwatsubo (2 shared papers)Stuart Pickering‐Brown (3 shared papers)F. Owen (2 shared papers)Yvonne Davies (1 shared paper)Wan-Kyng Liu (1 shared paper)Matt Baker (1 shared paper)Martin N. Rossor (1 shared paper)
- Journals
- Neuroreport (1 paper)Neurobiology of Aging (1 paper)International Journal of Geriatric Psychiatry (1 paper)Neurobiology of Disease (1 paper)Annals of Neurology (1 paper)
- Partner nations
- United KingdomJapanIreland
In The Last Decade
David Mann
6 papers receiving 209 citations
Peers
Comparison fields: 5 of 31
- Neurology 96
- Physiology 141
- Neurology 45
- Cellular and Molecular Neuroscience 34
- Pharmacology 25
Countries citing papers authored by David Mann
This map shows the geographic impact of David Mann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Mann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Mann more than expected).
Fields of papers citing papers by David Mann
This network shows the impact of papers produced by David Mann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Mann. The network helps show where David Mann may publish in the future.
Co-authors
The 25 scholars most cited alongside David Mann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 99 | |
| 2 | 2004 | 35 | |
| 3 | 2007 | 29 | |
| 4 | 1999 | 26 | |
| 5 | 2014 | 15 | |
| 6 | 1998 | 7 |
About David Mann
David Mann is a scholar working on Physiology, Molecular Biology, Neurology, Psychiatry and Mental health and Pharmacology, having authored 6 papers that have together received 211 indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (4 papers), Parkinson's Disease Mechanisms and Treatments (2 papers), Prion Diseases and Protein Misfolding (2 papers), Dementia and Cognitive Impairment Research (2 papers), Amyotrophic Lateral Sclerosis Research (1 paper), Nuclear Receptors and Signaling (1 paper), Neurogenetic and Muscular Disorders Research (1 paper) and Neurological diseases and metabolism (1 paper). The work is most often cited by research in Neurology (96 citations), Physiology (141 citations), Neurology (45 citations), Cellular and Molecular Neuroscience (34 citations) and Pharmacology (25 citations). David Mann has collaborated with scholars based in United Kingdom, Japan and Ireland. Frequent co-authors include Masato Hasegawa, Takeshi Iwatsubo, Stuart Pickering‐Brown, F. Owen, Yvonne Davies, Wan-Kyng Liu, Matt Baker, Martin N. Rossor, John Hardy and David Allsop. Their work appears in journals such as Neuroreport, Neurobiology of Aging, International Journal of Geriatric Psychiatry, Neurobiology of Disease and Annals of Neurology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.